Equity Profile

SYK

Stryker Corporation

Health CareHealth Care Equipment$127.1B

Jul30Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Stryker Corporation (SYK) is a leading medical technology company that develops and manufactures innovative healthcare equipment. With a market cap of $127 billion, Stryker plays a crucial role in the healthcare sector, providing products that enhance surgical procedures and patient care.

Key Metrics to Watch

EPS

Earnings per share (EPS) is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to increase sales, which is vital for sustaining its market position and funding future innovations.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

SYK Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+0.54%

Avg Stock Reaction

-0.54%

Last Quarter Recap

In Q1-2026, Stryker reported an EPS of $2.60, falling short of expectations by 12.63%. The stock did not move significantly the following day, indicating investor caution.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, Wall Street is cautious ahead of Stryker's earnings report, especially following the recent EPS miss. Investors are looking for signs of recovery in revenue and profitability.

Bull Case

If Stryker can demonstrate strong revenue growth and improved margins, it could signal a turnaround, boosting investor confidence.

Bear Case

Conversely, if the company fails to meet expectations again, it may raise concerns about its growth prospects and market position.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

The EPS figure will be critical in assessing whether Stryker can recover from its recent miss and regain investor confidence.

What is the outlook for revenue growth in the upcoming quarters?

Understanding the revenue growth trajectory will help gauge Stryker's ability to sustain its market position and innovate.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Stryker's potential for recovery, especially if the company can leverage its innovative product pipeline effectively.

Supporting Evidence

Stryker has a strong history of beating EPS estimates, with an 88% beat rate over the last eight quarters.

Options pricing suggests a lower expected volatility than historical averages, indicating potential for a surprise.

The recent miss may have created a buying opportunity for long-term investors.

Key Risk

If Stryker reports an EPS above $2.70, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is crucial for Stryker as it seeks to recover from recent earnings misses and demonstrate growth potential.

Bull Confirmed If

A positive EPS surprise of at least 5% would confirm the bull case.

Bear Confirmed If

An EPS miss of more than 10% would solidify the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±1.1%

Historical Avg

±0.8%

Pricing rich

The options market is pricing in a modest move of about 1.1% in either direction following the earnings report.

Options are pricing ±1.1% while SYK has averaged ±0.8% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

33.6%

Calls (73K)P/C Ratio: 2.01Puts (54K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Stryker beats expectations, history suggests the stock could rise by around 0.62%, confirming a recovery narrative.

In-Line / Cautious

If results are in line but cautious, the stock may see muted movement as investors await clearer guidance.

Miss

A significant miss could lead to a decline, with historical patterns suggesting a potential drop of around 0.00%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on cost management and margin improvement strategies.
3Insights into market demand trends for Stryker's key product lines.
4Guidance on future revenue growth and market expansion plans.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

KRCAMC

Kilroy Realty Corporation

PreviewView

Jul27

PIIAMC

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share (EPS) is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to increase sales, which is vital for sustaining its market position and funding future innovations.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

SYK Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+0.54%

Avg Stock Reaction

-0.54%

Last Quarter Recap

In Q1-2026, Stryker reported an EPS of $2.60, falling short of expectations by 12.63%. The stock did not move significantly the following day, indicating investor caution.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, Wall Street is cautious ahead of Stryker's earnings report, especially following the recent EPS miss. Investors are looking for signs of recovery in revenue and profitability.

Bull Case

If Stryker can demonstrate strong revenue growth and improved margins, it could signal a turnaround, boosting investor confidence.

Bear Case

Conversely, if the company fails to meet expectations again, it may raise concerns about its growth prospects and market position.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

The EPS figure will be critical in assessing whether Stryker can recover from its recent miss and regain investor confidence.

What is the outlook for revenue growth in the upcoming quarters?

Understanding the revenue growth trajectory will help gauge Stryker's ability to sustain its market position and innovate.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Stryker's potential for recovery, especially if the company can leverage its innovative product pipeline effectively.

Supporting Evidence

Stryker has a strong history of beating EPS estimates, with an 88% beat rate over the last eight quarters.

Options pricing suggests a lower expected volatility than historical averages, indicating potential for a surprise.

The recent miss may have created a buying opportunity for long-term investors.

Key Risk

If Stryker reports an EPS above $2.70, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is crucial for Stryker as it seeks to recover from recent earnings misses and demonstrate growth potential.

Bull Confirmed If

A positive EPS surprise of at least 5% would confirm the bull case.

Bear Confirmed If

An EPS miss of more than 10% would solidify the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±1.1%

Historical Avg

±0.8%

Pricing rich

The options market is pricing in a modest move of about 1.1% in either direction following the earnings report.

Options are pricing ±1.1% while SYK has averaged ±0.8% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

33.6%

Calls (73K)P/C Ratio: 2.01Puts (54K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Stryker beats expectations, history suggests the stock could rise by around 0.62%, confirming a recovery narrative.

In-Line / Cautious

If results are in line but cautious, the stock may see muted movement as investors await clearer guidance.

Miss

A significant miss could lead to a decline, with historical patterns suggesting a potential drop of around 0.00%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on cost management and margin improvement strategies.
3Insights into market demand trends for Stryker's key product lines.
4Guidance on future revenue growth and market expansion plans.